Form 4: NHC Senior VP Vicki Dodson Receives Restricted Stock Grant
Insider Transaction Report
National Healthcare Corp's Senior VP, Vicki L. Dodson, was granted 1,082 restricted shares of common stock, vesting over three years.
Summary
- Vicki L. Dodson, Senior VP Patient Services and a Director of National Healthcare Corp (NHC), acquired 1,082 shares of common stock.
- These shares were granted as restricted stock with a price of $0, indicating they are part of a compensation package.
- The restricted shares are subject to a three-year vesting schedule, with 33 1/3% vesting on January 1, 2027, January 1, 2028, and January 1, 2029, respectively.
- Following this transaction, Ms. Dodson directly beneficially owns 11,371.5455 shares of common stock.
- Ms. Dodson also holds several options to purchase common stock, totaling 39,234 shares, with exercise prices ranging from $53.94 to $157.13 and expiration dates between 2028 and 2031.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting ongoing executive alignment with shareholder interests through equity compensation, which is a standard and expected practice.
Positives
- The grant of restricted shares aligns the interests of Senior VP Vicki L. Dodson with those of shareholders, incentivizing long-term performance.
- The vesting schedule encourages retention of key management personnel over a three-year period.
- Ms. Dodson's significant holdings of both common stock and stock options demonstrate a substantial personal investment in the company's success.
Negatives
- The issuance of restricted stock, while a common compensation practice, represents a dilution of existing shareholder equity, albeit minor in this specific instance.
- The $0 price for the restricted shares means they are a direct compensation expense for the company.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that executive compensation, including restricted stock grants and stock options, is a standard practice across the healthcare industry to attract, retain, and incentivize senior leadership. This particular grant is consistent with typical compensation structures aimed at aligning executive interests with long-term shareholder value.
Related Party Transactions
- The grant of restricted shares to Vicki L. Dodson, a Senior VP and Director, constitutes a related party transaction as it involves compensation from the company to an executive.
Stakeholder Impact
- Shareholders: Potential minor dilution from the issuance of new shares for the restricted stock grant, but also increased alignment of executive incentives with long-term shareholder value.
- Employees: May signal stability in executive leadership and a commitment to performance-based compensation.
- Management: Vicki L. Dodson's compensation package is enhanced, providing a long-term incentive to contribute to the company's success.
Next Steps
- The restricted shares will vest in three equal tranches on January 1, 2027, January 1, 2028, and January 1, 2029.
- Ms. Dodson may exercise her outstanding stock options at various dates up to their respective expiration dates.
Key Dates
| Date | Description |
|---|---|
| 03/08/2024 | Date when 3,734 stock options became exercisable. |
| 03/05/2025 | Date when 8,000 stock options became exercisable. |
| 02/24/2026 | Date when 13,500 stock options became exercisable. |
| 02/27/2026 | Date of the restricted stock grant transaction. |
| 03/03/2026 | Date the Form 4 was signed by Vicki L. Dodson. |
| 01/01/2027 | First vesting date for 33 1/3% of the restricted shares. |
| 02/23/2027 | Date when 14,000 stock options became exercisable. |
| 01/01/2028 | Second vesting date for 33 1/3% of the restricted shares. |
| 03/08/2028 | Expiration date for 3,734 stock options. |
| 01/01/2029 | Final vesting date for 33 1/3% of the restricted shares. |
| 03/05/2029 | Expiration date for 8,000 stock options. |
| 02/24/2030 | Expiration date for 13,500 stock options. |
| 02/23/2031 | Expiration date for 14,000 stock options. |
Recommendation
holdThis Form 4 filing details a routine executive compensation event (restricted stock grant and existing stock options) and does not provide new fundamental information about National Healthcare Corp's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It primarily confirms ongoing executive alignment and compensation practices, which are generally expected.
Keywords
National Healthcare Corp, NHC, Vicki L Dodson, Form 4, Restricted Stock, Stock Options, Executive Compensation, Insider Trading, Beneficial Ownership, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.